Ms. Delvina Labrecque, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Smc 8 Audiology, Brighton, MA 02135 Phone: 617-789-5004 |
Amber Leigh Fields, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 774-285-3603 |
Dr. Naomi Bramhall, AU.D, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, St. Elizabeth's Medical Center Dept Of Otolaryngology, Brighton, MA 02135 Phone: 617-779-6442 |
Dr. Christina Elsa Hammer, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Smc-8, Brighton, MA 02135 Phone: 617-779-6456 Fax: 617-779-6485 |
Dr. Megan Kate Hoben, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Smc-8, Brighton, MA 02135 Phone: 617-562-7956 Fax: 617-789-5088 |
Mark Allen Parker, PHD, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Smc-8, Brighton, MA 02135 Phone: 617-562-7956 |
Mrs. Kathleen Breen Audiologist Medicare: Accepting Medicare Assignments Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-779-6460 Fax: 617-779-6485 |
News Archive
A new study of lung anatomy may explain why 1 in 4 cases of COPD-a lung disease most often linked to smoking-occur in people who have never smoked, a fact that has long perplexed researchers.
Emodin, a natural product that can be extracted from various Chinese herbs including Rheum palmatum and Polygonum cuspidatum, shows promise as an agent that could reduce the impact of type 2 diabetes. Findings published in this month's edition of the British Journal of Pharmacology show that giving emodin to mice with diet-induced obesity lowered blood glucose and serum insulin, improved insulin resistance and lead to more healthy levels of lipid in the blood. It also decreased body weight and reduced central fat mass.
The 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) brings together leading allergists and immunologists from around the world.
Trovagene, Inc., today announced it will expand the clinical collaboration with Genomac Research Institute in Prague, Czech Republic. Trovagene Precision Cancer Monitoring SM technology will be used in two prospective clinical studies for the early detection of emerging oncogene mutations indicative of resistance to targeted therapies used to treat colorectal and lung cancer.
Our bodies are constantly and successfully fighting off the development of cells that lead to tumours - but when there is disruption to this process cancer is free to develop.
› Verified 8 days ago